Bergfeld et al (2018) Safety assessment of fatty acids and soaps as used in cosmetics. In: The 2018 Cosmetic Ingredient Review Expert Panel members are: Chair, Wilma F. [Online]. Available: http://www.cir-safety.org/supplementaldoc/preliminary-search-engines-and

Bourgognon J, Suessmilch M, McColl A, Cavanagh J (2019) Abstract #4297 blood brain barrier breakdown following topical aldara treatment. Brain Behav Immun 81:24–25. https://doi.org/10.1016/j.bbi.2019.08.086

Article  Google Scholar 

Brück J, Dringen R, Amasuno A, Pau-Charles I, Ghoreschi K (2018) A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis. Exp Dermatol 27(6):611–624. https://doi.org/10.1111/exd.13548

Article  CAS  PubMed  Google Scholar 

Butchi NB, Pourciau S, Du M, Morgan TW, Peterson KE (2008) Analysis of the neuroinflammatory response to TLR7 stimulation in the brain: comparison of multiple TLR7 and/or TLR8 agonists. J Immunol 180(11):7604–7612. https://doi.org/10.4049/jimmunol.180.11.7604

Article  CAS  PubMed  Google Scholar 

Chiricozzi A, Romanelli P, Volpe E, Borsellino G, Romanelli M (2018) Scanning the immunopathogenesis of psoriasis. 19(1)

CIR (2013) Safety assessment of fatty acids and fatty acid salts as used in cosmetics

De Paula D, Martins CA, Bentley MVLB (2008) Development and validation of HPLC method for imiquimod determination in skin penetration studies. Biomed Chromatogr 22(12):1416–1423. https://doi.org/10.1002/bmc.1075

Article  CAS  PubMed  Google Scholar 

Del Rosso JQ (2005) The use of topical imiquimod for the treatment of actinic keratosis: a status report. Cutis 76(4):241–248

PubMed  Google Scholar 

Flutter B, Nestle FO (2013) TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis. Eur J Immunol 43(12):3138–3146. https://doi.org/10.1002/eji.201343801

Article  CAS  PubMed  Google Scholar 

Girolomoni G et al (2017) The role of IL-23 and the IL-23/TH17 immune axis in the pathogenesis and treatment of psoriasis. J Eur Acad Dermatol Venereol 31(10):1616–1626. https://doi.org/10.1111/jdv.14433

Article  CAS  PubMed  PubMed Central  Google Scholar 

Global Report on Psoriasis (2023)

Graceway Pharmaceuticals (2009) Center for drug evaluation and pharmacology review: 201153Orig1s000

Hawkes JE, Gudjonsson JE, Ward NL (2017) The snowballing literature on imiquimod-induced skin inflammation in mice: a critical appraisal. J Invest Dermatol 137(3):546–549. https://doi.org/10.1016/j.jid.2016.10.024

Article  CAS  PubMed  Google Scholar 

Horváth S, Komlódi R, Perkecz A, Pintér E, Gyulai R, Kemény Á (2019) Methodological refinement of Aldara-induced psoriasiform dermatitis model in mice. Sci Rep 9(1):1–8. https://doi.org/10.1038/s41598-019-39903-x

Article  CAS  Google Scholar 

Horváth S, Kemény Á, Pintér E, Gyulai R (2020) A localized aldara (5% imiquimod)–induced psoriasiform dermatitis model in mice using Finn chambers. Curr Protoc Pharmacol 90(1):1–12. https://doi.org/10.1002/cpph.78

Article  CAS  Google Scholar 

Jabeen M et al (2020) Advanced characterization of imiquimod-induced psoriasis-like mouse model. Pharmaceutics 12(9):1–18. https://doi.org/10.3390/pharmaceutics12090789

Article  CAS  Google Scholar 

Luo D, Wu H, Zhao Y, Liu J, Wang F (2016) Different imiquimod creams resulting in differential effects for imiquimod-induced psoriatic mouse models. 1733–1738. https://doi.org/10.1177/1535370216647183

McColl A, Thomson CA, Nerurkar L, Graham GJ, Cavanagh J (2016) TLR7-mediated skin inflammation remotely triggers chemokine expression and leukocyte accumulation in the brain. J Neuroinflammation 13(1):1–16. https://doi.org/10.1186/s12974-016-0562-2

Article  CAS  Google Scholar 

Nakajima K, Sano S (2018) Mouse models of psoriasis and their relevance. J Dermatol 45(3):252–263. https://doi.org/10.1111/1346-8138.14112

Article  PubMed  Google Scholar 

Nerurkar L, Mccoll A, Graham G, Cavanagh J (2017) The systemic response to topical aldara treatment is mediated through direct TLR7 stimulation as imiquimod enters the circulation. Sci Rep. https://doi.org/10.1038/s41598-017-16707-5

Article  PubMed  PubMed Central  Google Scholar 

Pockros PJ et al (2007) Oral resiquimod in chronic HCV infection: Safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies. J Hepatol 47(2):174–182. https://doi.org/10.1016/j.jhep.2007.02.025

Article  CAS  PubMed  Google Scholar 

Schön MP, Schön M (2007) Imiquimod: mode of action. Br J Dermatol 157(SUPPL. 2):8–13. https://doi.org/10.1111/j.1365-2133.2007.08265.x

Article  CAS  PubMed  Google Scholar 

Schön MP, Schön M, Klotz KN (2006) The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7- and TLR8-independent fashion. J Invest Dermatol 126(6):1338–1347. https://doi.org/10.1038/sj.jid.5700286

Article  CAS  PubMed  Google Scholar 

Straß S, Schwamborn A, Keppler M, Guse J, Burnet M (2021) Synthesis, characterization and in vivo distribution of intracellular delivered macrolide SCFA derivatives. 1–16. https://doi.org/10.1002/cmdc.202100139

Sun L et al (2018) Comparison of normal versus imiquimod-induced psoriatic skin in mice for penetration of drugs and nanoparticles. Int J Nanomed 13:5625–5635. https://doi.org/10.2147/IJN.S170832

Article  CAS  Google Scholar 

Telò I, Pescina S, Padula C, Santi P, Nicoli S (2016) Mechanisms of imiquimod skin penetration. Int J Pharm 511(1):516–523. https://doi.org/10.1016/j.ijpharm.2016.07.043

Article  CAS  PubMed  Google Scholar 

van den Höfel N (2018) Basiscreme DAC. https://flexikon.doccheck.com/de/Basiscreme_DAC#

van der Fits L et al (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182(9):5836–5845. https://doi.org/10.4049/jimmunol.0802999

Article  CAS  PubMed  Google Scholar 

Walter A et al (2013) Aldara activates TLR7-independent immune defence. Nat Commun 4(1):1–13. https://doi.org/10.1038/ncomms2566

Article  CAS  Google Scholar 

Wolff F, Loipetzberger A, Gruber W, Esterbauer H, Aberger F, Frischauf AM (2013) Imiquimod directly inhibits Hedgehog signalling by stimulating adenosine receptor/protein kinase A-mediated GLI phosphorylation. Oncogene 32(50):5574–5581. https://doi.org/10.1038/onc.2013.343

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang K, Oak ASW, Elewski BE (2021) Use of IL-23 inhibitors for the treatment of plaque psoriasis and psoriatic arthritis: a comprehensive review. Am J Clin Dermatol 22(2):173–192. https://doi.org/10.1007/s40257-020-00578-0

Article  PubMed  Google Scholar 

Zhang D et al (2022) Comparison of efficacy of anti-interleukin-17 in the treatment of psoriasis between caucasians and asians: a systematic review and meta-analysis. Front Med 8(January):1–9. https://doi.org/10.3389/fmed.2021.814938

Article  Google Scholar